同濟科技(600846.SH):子公司中標12.66億元項目工程
格隆匯6月1日丨同濟科技(600846.SH)公佈,全資子公司上海同濟建設有限公司收到上海數宇雲圖科技發展有限公司發出的中標通知書,上海同濟建設有限公司通過公開招標方式,中標上海市楊浦區長海路街道334、336街坊辦公項目工程。
該項目位於上海市楊浦區長海路街道,東至規劃國京路,西至閘殷路,南至014-02地塊,北至殷高東路。該項目建築面積144,115.38平方米,中標範圍和內容:施工圖範圍內的圍護、土方、樁基、土建、機電、外總體等工程。該工程項目中標價格12.66億元,中標工期1048日曆天。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.